Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Egidio Celentano.
Paolo Ascierto
Connection Strength
0.515
Egidio Celentano
  1. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med. 2021 03 31; 19(1):132.
    View in: PubMed
    Score: 0.234
  2. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2).
    View in: PubMed
    Score: 0.224
  3. The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic. Infect Agent Cancer. 2020 Nov 23; 15(1):69.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.